ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
拨康视云－Ｂ
5.200
+0.090
1.76%
手动刷新
成交量：
12.25万
成交额：
63.32万
市值：
43.62亿
市盈率：
-3.19
高：
5.220
开：
5.140
低：
5.110
收：
5.110
52周最高：
9.740
52周最低：
4.930
股本：
8.39亿
香港流通股本：
8.39亿
量比：
0.27
换手率：
0.01%
股息：
- -
股息率：
- -
每股收益(LYR):
-1.628
净资产收益率：
--
总资产收益率：
-44.38%
市净率：
-1.59
市盈率(LYR):
-3.19
市销率:
55.88
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字：
拨康视云－Ｂ
交易所：
SEHK
成立时间：
2015
员工人数：
51
公司地址：
8921 Research Drive,Irvine,California,United States
官网：
http://cloudbreakpharma.com
邮编：
92618
电话：
- -
传真：
- -
简介：
Cloudbreak Pharma(拨康视云)是一家在临床阶段的眼科药物公司。公司于2015年9月在美国加州尔湾市成立。我们团队拥有多元化的技能和丰富的眼科药物研发经验。 我们的眼睛不仅仅是视觉工具。我们通过眼睛与周围的人和世界联系和沟通。拨康视云的使命是确保没有人因眼睛健康情况不佳而受到阻碍。我们的目标是通过治疗各种损害视力和生活品质的眼部疾病来帮助人们更好的享受生活。 我们是一家临床阶段的全球生物技术公司,开发治疗慢性眼病的眼科药物,这些疾病的治疗选择往往很少。我们广泛的产品线是由拥有经验和专业知识的内部科学家开发的,以发现新的有真对性的作用机制和适合局部眼部给药的配方。我们对眼科疾病发病机制的深入了解和广泛的科学知识使我们开发出我们的主要候选产品 CBT-001,这是一种研究阶段滴眼剂治疗方法,有可能减缓或阻止翼状胬肉的进展,翼状胬肉是一种高度诊断不足和治疗不足的疾病, 尚未有获得批准的药物治疗方式。
董事
名称
职位
NI Jinsong
董事会主席，执行董事
Van Son DINH
执行董事
YANG Rong
执行董事
赖显荣
独立非执行董事，薪酬委员会委员，提名委员会主席，审核委员会委员
廖仲敏
独立非执行董事，薪酬委员会委员，提名委员会委员，审核委员会主席
聂四江
独立非执行董事，薪酬委员会主席，提名委员会委员，审核委员会委员
LI Jun Zhi
非执行董事
曹旭
非执行董事
夏志东
非执行董事
股东
名称
职位
NI Jinsong
首席执行官
陈清珠
首席财务官
冯雅芳
财务总监，公司秘书
Elizabeth Sharon CAPAN
首席合规官，首席专利官
Van Son DINH
首席营运官
YANG Rong
首席科学官
Abu P ABRAHAM
首席医疗官
FANG Wenkui Ken
首席创新官
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02592/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"拨康视云－Ｂ","latestPrice":5.2,"timestamp":1756092301231,"preClose":5.11,"halted":0,"volume":122500,"delay":0,"floatShares":838892874,"shares":838892874,"eps":-1.6277027554445398,"marketStatus":"交易中","change":0.09,"latestTime":"08-25 11:30:03","open":5.14,"high":5.22,"low":5.11,"amount":633170,"amplitude":0.021526,"askPrice":5.21,"askSize":48500,"bidPrice":5.19,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-1.6277027554445398,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1756094400000},"marketStatusCode":2,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":5.11,"openAndCloseTimeList":[[1756085400000,1756094400000],[1756098000000,1756108800000]],"volumeRatio":0.265063,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":838892874,"roa":"-44.38%","roe":"--","lyrEps":-1.627703,"volumeRatio":0.265063,"shares":838892874,"dividePrice":0,"high":5.22,"amplitude":0.021526,"preClose":5.11,"low":5.11,"week52Low":4.93,"pbRate":"-1.59","psRate":"55.88","week52High":9.74,"institutionHeld":0,"latestPrice":5.2,"committee":-0.959596,"eps":-1.6277027554445398,"divideRate":0,"volume":122500,"delay":0,"ttmEps":-1.6277027554445398,"open":5.14,"prevYearClose":10.1,"prevWeekClose":5.11,"prevMonthClose":5.35,"prevQuarterClose":10.1,"fiveDayClose":5.33,"twentyDayClose":5.57,"sixtyDayClose":10.1,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2025-08-22","current":-5.53457,"percent":0.833333,"low":-6.683808,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"high":-5.433303,"avg":-5.958993,"sd":0.37199,"marketCap":4286742586},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586}],"updateTime":1756086142924},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1934212103,"yearFounded":2015,"employeeNum":51,"address":"8921 Research Drive,Irvine,California,United States","zipCode":"92618"},"stockCompanyDetail":{"websiteUrl":"http://cloudbreakpharma.com","stockEarnings":[{"period":"1week","weight":-0.0358},{"period":"1month","weight":-0.1098},{"period":"3month","weight":-0.4941},{"period":"ytd","weight":-0.4941}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0736},{"period":"6month","weight":0.0793},{"period":"1year","weight":0.4364},{"period":"ytd","weight":0.2632}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Cloudbreak Pharma(拨康视云)是一家在临床阶段的眼科药物公司。公司于2015年9月在美国加州尔湾市成立。我们团队拥有多元化的技能和丰富的眼科药物研发经验。\n我们的眼睛不仅仅是视觉工具。我们通过眼睛与周围的人和世界联系和沟通。拨康视云的使命是确保没有人因眼睛健康情况不佳而受到阻碍。我们的目标是通过治疗各种损害视力和生活品质的眼部疾病来帮助人们更好的享受生活。\n我们是一家临床阶段的全球生物技术公司,开发治疗慢性眼病的眼科药物,这些疾病的治疗选择往往很少。我们广泛的产品线是由拥有经验和专业知识的内部科学家开发的,以发现新的有真对性的作用机制和适合局部眼部给药的配方。我们对眼科疾病发病机制的深入了解和广泛的科学知识使我们开发出我们的主要候选产品 CBT-001,这是一种研究阶段滴眼剂治疗方法,有可能减缓或阻止翼状胬肉的进展,翼状胬肉是一种高度诊断不足和治疗不足的疾病, 尚未有获得批准的药物治疗方式。","exchange":"SEHK","name":"拨康视云－Ｂ","nameEN":"CLOUDBREAK-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":{"directors":[{"name":"NI Jinsong","position":"董事会主席，执行董事"},{"name":"Van Son DINH","position":"执行董事"},{"name":"YANG Rong","position":"执行董事"},{"name":"赖显荣","position":"独立非执行董事，薪酬委员会委员，提名委员会主席，审核委员会委员"},{"name":"廖仲敏","position":"独立非执行董事，薪酬委员会委员，提名委员会委员，审核委员会主席"},{"name":"聂四江","position":"独立非执行董事，薪酬委员会主席，提名委员会委员，审核委员会委员"},{"name":"LI Jun Zhi","position":"非执行董事"},{"name":"曹旭","position":"非执行董事"},{"name":"夏志东","position":"非执行董事"}],"executives":[{"name":"NI Jinsong","position":"首席执行官"},{"name":"陈清珠","position":"首席财务官"},{"name":"冯雅芳","position":"财务总监，公司秘书"},{"name":"Elizabeth Sharon CAPAN","position":"首席合规官，首席专利官"},{"name":"Van Son DINH","position":"首席营运官"},{"name":"YANG Rong","position":"首席科学官"},{"name":"Abu P ABRAHAM","position":"首席医疗官"},{"name":"FANG Wenkui Ken","position":"首席创新官"}]}}}